Skip to content

Expanding Reach of Evidence-based Psychotherapy for Veterans With Co-occurring Anxiety and Substance Use Disorders.

Expanding Reach of Evidence-based Psychotherapy for Rural Veterans With Co-occurring Anxiety and Substance Use Disorders.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05372185
Enrollment
26
Registered
2022-05-12
Start date
2022-04-25
Completion date
2024-03-30
Last updated
2024-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety Disorders, Substance Use Disorders

Brief summary

The current study seeks to better understand how to improve access to evidence-based psychotherapy (EBP) for rural Veterans with co-occurring anxiety and substance use disorders (SUD) using a web-based cognitive behavioral therapy tool (VA Coordinated Anxiety Learning and Management, Substance Use Version; VA CALM-S).

Interventions

BEHAVIORALVA Coordinated Anxiety Learning and Management- Substance Use Version

VA Coordinated Anxiety Learning and Management- Substance Use Version (VA CALM-S) is a cognitive behavior therapy (CBT) program that employs computer assistance to empower providers to deliver CBT with high fidelity. The computer program guides both providers and patients in a course of CBT, and in this study the content will focus on using transdiagnostic treatment elements to address co-occurring anxiety and substance use disorders.

BEHAVIORALUsual care

Veterans will engage in VA care using the standard procedures of their facility.

Sponsors

Baylor College of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* current anxiety disorder diagnosis * current SUD

Exclusion criteria

* current substance withdrawal such that medically supervised detoxification is necessary (determined by evaluation of substance use history and report of current symptoms), * acute suicidality * current delusions/hallucinations.

Design outcomes

Primary

MeasureTime frameDescription
Generalized Anxiety Disorder-712 weeksSelf report measure of anxiety symptoms (score range 0-21), higher scores indicate greater anxiety (i.e., poorer outcome).

Secondary

MeasureTime frameDescription
Substance use frequency12 weeksNumber of substance use days

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026